¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"generalised Shwartzman phenomenon"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® rebound phenomenon ÇÑ±Û ¹Ý¹ßÇö»ó, ¹Ýµ¿Çö»ó
¼³¸í   
  ¼Ò³ú ±â´ÉÀå¾Ö¿¡¼­ »çÁöÀÇ ´ëÇ×±ÙÀ° »çÀÌÀÇ ÇùÁ¶¼º »ó½ÇÀǠ¡Èķμ­, È¯ÀÚ¿¡°Ô ¾çÆÈÀ» ¼öÆòÀ¸·Î »¸°Ô ÇÏ°í ±× ÆÈÀ» °­ÇϰԠġ¸é Á¤»óÀΠ°æ¿ì´Â °ð ¿ø»óÀ¸·Î ¿Ã¸®´Âµ¥ ºñÇÏ¿© È¯ÀÚ¿¡ À־´Â ¿øÀ§Ä¡·Î µ¹¾Æ¿À´Â µ¥ ¸î ¹øÀ̳ª ¶³°Ô µÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aqueous-influx phenomenon
    ¹æ¼öÀ¯ÀÔÇö»ó
  • adoption phenomenon
    ä¿ëÇö»ó
  • clasp-knife phenomenon
    Á¢´ÂÄ®Çö»ó
  • closing-in phenomenon
    Á¾°áÇö»ó
  • critical phenomenon
    ÀÓ°èÇö»ó
  • crowding phenomenon
    ¹ÐÁýÇö»ó
  • cytopathogenic phenomenon
    ¼¼Æ÷º¯¼ºÇö»ó
  • centralization phenomenon
    Áß½ÉÈ­Çö»ó
  • duplication phenomenon
    º¹Á¦Çö»ó
  • delay phenomenon
    Áö¿¬Çö»ó
  • dawn phenomenon
    »õº®Çö»ó, ¿©¸íÇö»ó
  • discontinuity phenomenon
    ºÒ¿¬¼ÓÇö»ó
  • dissociative phenomenon
    ÇØ¸®Çö»ó
  • doll¡¯s head phenomenon
    ÀÎÇü¸Ó¸®Çö»ó
  • entoptic phenomenon
    ³»½ÃÇö»ó
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phenomenon
    Çö»ó
  • phantom phenomenon
    ÇêÇö»ó, ȯ»óÇö»ó
  • rebound phenomenon
    ¹Ýµ¿Çö»ó
  • recruitment phenomenon
    Á¡ÁõÇö»ó, ´©°¡Çö»ó, º¸ÃæÇö»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adoption phenomenon
    ä¿ëÇö»ó
  • aqueous-influx phenomenon
    ¹æ¼öÀ¯ÀÔÇö»ó
  • clasp-knife phenomenon
    Á¢´ÂÄ®Çö»ó
  • closing-in phenomenon
    Á¾°áÇö»ó
  • critical phenomenon
    ÀÓ°èÇö»ó
  • crowding phenomenon
    ¹ÐÁýÇö»ó
  • cytopathogenic phenomenon
    ¼¼Æ÷º¯¼ºÇö»ó
  • delay phenomenon
    Áö¿¬Çö»ó
  • discontinuity phenomenon
    ºÒ¿¬¼ÓÇö»ó
  • dissociative phenomenon
    ÇØ¸®Çö»ó
  • doll¡¯s head phenomenon
    ÀÎÇü¸Ó¸®Çö»ó
  • down phenomenon
    »õº®Çö»ó, ¿©¸íÇö»ó
  • duplication phenomenon
    º¹Á¦Çö»ó
  • entoptic phenomenon
    ³»½ÃÇö»ó
  • entry phenomenon
    ÁøÀÔÇö»ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Shwartzman phenomenon
    ½´¹Ù¸£Ã÷¸¸ Çö»ó
  • Sanarelli-Shwartzman reaction
    »ç³ª·¼¸®-½´¹ßÂ길¹ÝÀÀ
  • Arthus phenomenon
    ¾Æ¸£Åõ½º Çö»ó(~ úÞßÚ)
  • Arthuss phenomenon
    ¾Æ¸£Åõ½ºÇö»ó
  • Bells phenomenon
    º§Çö»ó
  • CRST(Calcinosis, Raynauds phenomenon, Sclerodactyly, Telangiectasia) syndrome
    CRST ÁõÈıº.
  • Chameleon phenomenon
    Ä«¸á·¹¿ÂÇö»ó.
  • Danysz phenomenon
    Danysz Çö»ó
  • Danyszs phenomenon
    ´Ù´ÏÁî Çö»ó
  • Faraday s phenomenon
    ÆÐ·¯µ¥ÀÌÇö»ó.
  • Fowler phenomenon
    º¸ÃæÇö»ó
  • Gibbs phenomenon
    ±é½º Çö»ó
  • Gunns pupillary phenomenon
    °Ç¾¾µ¿°øÇö»ó
  • Hirsts phenomenon
    Ç㽺Ʈ Çö»ó
  • Jack-in-the-box phenomenon
    µ¹¿¬½ÃÇö»ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lupus erythematosus phenomenon = LE phenomenon
    È«¹Ý¼º ·çǪ½ºÇö»ó(¡­úÞßÚ)
  • anamnestic phenomenon
    ±â¿ÕÇö»ó (¡­úÞßÚ).
  • anamnestic phenomenon
    ¸é¿ª[ÇÐÀû]±â¾ï[Çö»ó]
  • aqueous-influx phenomenon
    ¹æ¼öÀ¯ÀÔÇö»ó
  • arm phenomenon
    ÆÈ Çö»ó.
  • autoscopic phenomenon
    ÀÚ±âȯ¿µÇö»ó
  • blanching phenomenon
    â¹éÇö»ó(óïÛÜúÞßÚ).
  • blue-field entopic phenomenon
    û»ö½Ã¾ß³»½ÃÇö»ó
  • blush-and-blanch phenomenon
    È«Á¶Ã¢¹éÇö»ó(ûõðÍóïÛÜúÞßÚ).
  • break off phenomenon
    ÀÌÅ»°¨°¢Çö»ó(ìÆ÷­ÊïÊÆúÞßÚ)
  • break phenomenon
    ±úÁüÇö»ó, ÆÄ¿­Çö»ó
  • bulbar phenomenon
    ¿¬¼öÇö»ó.
  • cervicolumbar phenomenon
    °æ¿äÇö»ó(Ìòé¦úÞßÚ).
  • clasp knife phenomenon
    Á¢´Â Ä® Çö»ó
  • clasp-knife phenomenon
    Á¢´Â Ä® Çö»ó.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Sarle's phenomenon
    »ì·¹Çö»ó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Danysz phenomenon
    ´ë´ÏÁî Çö»ó(úÞßÚ)
  • ectrokinetic phenomenon
    °è¸éµ¿Àü±â Çö»ó(Í£ØüÔÑï³Ñ¨úÞßÚ)
  • plateau phenomenon
    Ç÷¡Åä Çö»ó(úÞßÚ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • entry phenomenon
    ÁøÀÔÇö»ó
  • entry slice phenomenon
    À¯ÀԴܸéÇö»ó
  • flare phenomenon
    Àå°³Çö»ó
  • Gibbs phenomenon
    ±é½ºÇö»ó
  • iceberg phenomenon
    ºù»ê Çö»ó
  • phenomenon
    Çö»ó
  • rebound phenomenon
    ¹Ýµ¿Çö»ó
  • slice entry phenomenon
    ÀýÆíÀÔ±¸Çö»ó
  • sunset phenomenon
    ÀϸôÇö»ó
  • time of flight phenomenon
    À¯Ã¼¼Óµµ°­Á¶Çö»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SSP Sanarelli-Shwartzman phenomenon; subacute sclerosing panencephalitis; slice sensitivity profile; sub...
GSR galvanic skin response; generalized Shwartzman reaction; glutathione reductase
GSSR generalized Sanarelli-Shwartzman reaction
SGR Sachs-Georgi reaction; Shwartzman generalized reaction; skin galvanic reflex; submandibular gland re...
SLR Shwartzman local reaction; single lens reflex; straight leg raising
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
GSR Generalized Shwartzman reaction
PRP Primary Raynaud's Phenomenon
RP Raynaud Phenomenon
GAM Generalised Additive Models
GAD Generalised Anxiety Disorder
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • aldosterone escape phenomenon
    ¾Ëµµ½ºÅ×·Ð ¹èÃâ Çö»ó
    ¼¼Æ÷ ¿Ü¾×ÀÌ ¾î´À Á¤µµ Áõ°¡Çϸé aldosteroneÀÇ ºÐºñ°¡ °è¼Ó Áõ°¡ÇÏ´õ¶óµµ ³ªÆ®·ýÀÇ ¹è¼³ÀÌ Áõ°¡ÇÏ´Â Çö»óÀ» ¸»ÇÑ´Ù. ÀÌ Çö»óÀº ¼¼Æ÷ ¿Ü¾×ÀÇ Áõ°¡¿Í ÀϺδ ANH
  • aqueous-influx phenomenon
    ¹æ¼ö À¯ÀÔ Çö»ó
  • arthus phenomenon
    ¾Æ¸£Æ©½º Çö»ó
  • central pain phenomenon
    ÁßÃß¼º µ¿Åë Çö»ó
  • Chiristensen phenomenon
    Å©¸®½ºÅÙ¼¾ Çö»ó
    ÇϾÇÀÇ Àü¹æ¿îµ¿ ½Ã ´ëÇÕÇÏ´Â ±³ÇÕ¸é »çÀÌ¿¡ »ý±â´Â °£°Ý.
  • Christensen's phenomenon
    Å©¸®½ºÅÙ¼¾ Çö»ó
  • Class Switching phenomenon
    ºÐ·ù Àüȯ Çö»ó
    ÇϳªÀÇ B ¼¼Æ÷°¡ ±×¿¡ »óÀÀÇÒ ¼ö Àִ ƯÀÌ Ç׿ø¿¡ Á¢ÇÏ¿´À» ¶§ isoty
  • dawn phenomenon
    »õº® Çö»ó
    Á¦ 1Çü ´ç´¢º´ ȯÀÚÀÇ 75%¿¡¼­, ±×¸®°í ´Ù¼öÀÇ Á¦ 2Çü ´ç´¢º´ ȯÀÚ ¹× Á¤»óÀο¡¼­µµ ÀϾ´Ù. À̰ÍÀº ¿ÀÀü 5-8½Ã »çÀÌ¿¡ Àν¶¸°¿¡ ´ëÇÑ Á¶Á÷ÀÇ °¨¼ö¼ºÀÌ °¨¼ÒÇÏ¿© ÀϾ´Ù. ÃÖ±ÙÀÇ Áõ°Å´Â ÀÌ Çö»óÀÌ ¼ö¸é Áß¿¡ ¼ºÀå È£¸£¸ó ºÐºñÀÇ Áõ°¡¿¡ ÀÇÇÏ¿© À¯¹ßµÇ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. »õº® Çö»óÀÌ ´Üµ¶À» ¹ß»ýÇϸé À̸¥ ¾ÆÄ§¿¡ °æµµÀÇ °íÇ÷´çÁõÀÌ ¿À³ª ¼Ò¸ð±â È¿°ú³ª °¨Åð Çö»óÀÌ µ¿¹ÝµÇ¸é °íÇ÷´çÁõÀº ½ÉÇØÁø´Ù.
  • dolls head phenomenon
    ÀÎÇü ¸Ó¸® Çö»ó, ÀÎÇü µÎ Çö»ó
  • flare phenomenon
    Àå°³ Çö»ó
  • Fowler phenomenon
    º¸Ãæ Çö»ó
  • iceberg phenomenon
    ºù»ê Çö»ó
  • jaw winking phenomenon
    ÅÎ-À®Å© Çö»ó
  • light absorption phenomenon
    ºû Èí¼ö Çö»ó
  • metallic phenomenon
    ±Ý¼Ó¼º Çö»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
generalised Shwartzman phenomenon When both the primary injection of endotoxin-containing filtrate and the secondary injection are given intravenously 24 hours apart, the animal usually dies within 24 hours after the second inoculation; the characteristic lesions in the rabbit include widespread haemorrhages in the lung, liver, and other organs and bilateral cortical necrosis of the kidney. This reaction has no immunological basis.
Synonym: Sanarelli phenomenon, Sanarelli-Shwartzman phenomenon.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
Sanarelli-Shwartzman phenomenon When both the primary injection of endotoxin-containing filtrate and the secondary injection are given intravenously 24 hours apart, the animal usually dies within 24 hours after the second inoculation; the characteristic lesions in the rabbit include widespread haemorrhages in the lung, liver, and other organs and bilateral cortical necrosis of the kidney. This reaction has no immunological basis.
Synonym: Sanarelli phenomenon, Sanarelli-Shwartzman phenomenon.
(05 Mar 2000)
shwartzman phenomenon A two-stage reaction in which a first encounter with endotoxin produces intravascular fibrin thrombi whose clearance results in reticuloendothelial blockade which prevents the clearance of thrombi caused by a second encounter with endotoxin, resulting in tissue necrosis and/or haemorrhage. In pregnancy gram-negative septicaemia during delivery or abortion may serve as the first or provocative encounter. The phenomenon is non-immunologic and is known to occur only in rabbits and man.
(12 Dec 1998)
Shwartzman, Gregory <person> Russian bacteriologist in U.S., 1896-1965.
See: Shwartzman phenomenon, Shwartzman reaction, generalised Shwartzman phenomenon, Sanarelli-Shwartzman phenomenon.
(05 Mar 2000)
Shwartzman reaction <investigation> Reaction that occurs when two injections of endotoxin are given to the same animal, particularly rabbits, 24h apart. In the local Shwartzman reaction the first injection is given intradermally, the second intravenously and a haemorrhagic reaction develops at the dermal site. If both injections are intravenous the result is a generalised Shwartzman reaction, often accompanied by disseminated intravascular coagulation. The reaction depends upon the response of platelets and neutrophils to endotoxin.
(18 Nov 1997)
generalised <zoology> Comprising structural characters which are separated in more specialized forms; synthetic; as, a generalised type.
Source: Websters Dictionary
(01 Mar 1998)
generalised anaphylaxis The immediate response, involving smooth muscles and capillaries throughout the body of a sensitised individual, that follows intravenous (and occasionally intracutaneous) injection of antigen (allergen).
See: anaphylactic shock.
Synonym: systemic anaphylaxis.
(05 Mar 2000)
generalised anxiety disorder Chronic, repeated episodes of anxiety reactions; a psychological disorder in which anxiety or morbid fear and dread accompanied by autonomic changes are prominent features.
See: anxiety.
(05 Mar 2000)
generalised chondromalacia A degenerative disease of cartilage producing a bizarre form of arthritis, with collapse of the ears, the cartilaginous portion of the nose, and the tracheobronchial tree; death may occur from chronic infection or suffocation because of loss of stability in the tracheobronchial tree of autosomal origin.
Synonym: chronic atrophic polychondritis, generalised chondromalacia, Meyenburg's disease, Meyenburg-Altherr-Uehlinger syndrome, relapsing perichondritis, systemic chondromalacia, von Meyenburg's disease.
(05 Mar 2000)
generalised cortical hyperostosis <syndrome> An inherited skeletal dysplasia, with mandibular enlargement and thickening of the diaphyses and calvaria, and increased serum alkaline phosphatase; autosomal recessive inheritance.
Synonym: generalised cortical hyperostosis.
(05 Mar 2000)
generalised elastolysis A group of connective tissue diseases in which skin hangs in loose pendulous folds. It is believed to be associated with decreased elastic tissue formation as well as an abnormality in elastin formation. Cutis laxa is usually a genetic disease, but acquired cases have been reported.
(12 Dec 1998)
generalised emphysema Emphysema affecting all parts of the lobules, in part, or usually the whole, of the lungs, and usually associated with a1-antiprotease deficiency emphysema.
Synonym: diffuse emphysema, generalised emphysema, panacinar emphysema.
(05 Mar 2000)
generalised epidermolytic hyperkeratosis Diffusely red, eroded skin at birth, with subsequent scaling, tending to improve in later life, characterised by generalised epidermolytic hyperkeratosis and autosomal dominant inheritance.
See: epidermolytic hyperkeratosis.
Synonym: generalised epidermolytic hyperkeratosis, ichthyismus hystrix, ichthyosis hystrix.
(05 Mar 2000)
generalised epilepsy A major category of epilepsy syndromes characterised by one or more types of generalised seizures.
(05 Mar 2000)
generalised eruptive histiocytoma A rare recurring generalised eruption in adults of flesh coloured or erythematous papules remaining localised to the skin and consisting of dermal nodules of mononuclear histiocytes that do not stain for lipid.
Synonym: nodular non-X histiocytosis.
(05 Mar 2000)
generalised gangliosidosis Three forms exist: infantile, generalised; juvenile; and adult; gangliosidosis characterised by accumulation of a specific monosialoganglioside, GM1; due to deficiency of GM1-beta-galactosidase.
Synonym: generalised gangliosidosis.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phenomenon
    »ç°Ç; Çö»ó
  • Raynaud's phenomenon
    ·¹À̳ë Çö»ó(¼ÕÀÇ ¼Òµ¿¸Æ ¼öÃà¿¡ ÀÇÇÑ ÀϽÃÀû Ç÷¾× ºÎÁ·À¸·Î ¼Õ°¡¶ô.¼ÕÀÇ ÀϺΰ¡ â¹éÇØ Áö´Â Çö»ó)
  • dellinger phenomenon
    µ¨¸°Àú Çö»ó 9
  • phenomenon
    Çö»ó;°æÀÌ;Áø±âÇÑ »ç¹°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á